Novavax, Inc (NVAX) looking to reclaim success with recent performance
With 5.15 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.5 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.125 whereas the lowest price it dropped to was $6.87. The 52-week range on NVAX shows […]
Get in on Novavax, Inc’s (NVAX) buy-in window today!
With 7.4 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.34 million shares. The 52-week range on NVAX shows that it touched its highest point at $23.86 and its lowest point at $5.01 during that stretch. It currently has a 1-year price target of $14.67. Beta for […]
Novavax, Inc (NVAX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals
With 9.22 million shares changed hands, the volume of the stock remained heavier than its average volume of 8.27 million shares. The 52-week range on NVAX shows that it touched its highest point at $23.86 and its lowest point at $5.01 during that stretch. It currently has a 1-year price target of $15.29. Beta for […]
Novavax, Inc (NVAX) is looking forward to a strong quarter
With 7.26 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.21 million shares. The 52-week range on NVAX shows that it touched its highest point at $23.86 and its lowest point at $5.01 during that stretch. It currently has a 1-year price target of $15.29. Beta for […]
A better buy-in window may exist right now for Novavax, Inc (NVAX)
With 22.94 million shares changed hands, the volume of the stock remained heavier than its average volume of 7.95 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $8.235 whereas the lowest price it dropped to was $7.36. The 52-week range on NVAX shows […]
A better buy-in window may exist right now for Novavax, Inc (NVAX)
With 10.23 million shares changed hands, the volume of the stock remained heavier than its average volume of 6.12 million shares. The 52-week range on NVAX shows that it touched its highest point at $23.86 and its lowest point at $5.01 during that stretch. It currently has a 1-year price target of $15.29. Beta for […]
It makes sense and dollars to buy Novavax, Inc (NVAX) stock
With 10.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.23 million shares. The 52-week range on NVAX shows that it touched its highest point at $23.86 and its lowest point at $4.43 during that stretch. It currently has a 1-year price target of $15.57. Beta for […]
Novavax, Inc (NVAX) can make a big difference with a little luck
With 5.68 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.1 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.35 whereas the lowest price it dropped to was $6.655. The 52-week range on NVAX shows […]